Soiken Holdings Inc.

2385

JP3431850001

Personal Products

Delayed Japan Exchange Other stock markets 08:33:45 2024-04-24 pm EDT			5-day change	1st Jan Change
167 ^JPY	-0.60%		-0.60%	-0.60%

2023	Soiken Holdings Inc. Reports Earnings Results for the Nine Months Ended March 31, 2023	CI
2021	Hangzhou Golong Holding Co., Ltd. agreed to acquire 10.7% stake in Soiken Holdings Inc. from Tomoko Kajimoto for ?1.1 billion.	CI

Soiken Holdings Inc.(TSE:2385) dropped from S&P Global BMI Index

September 20, 2021 at 12:00 am EDT

Latest news about Soiken Holdings Inc.

Soiken Holdings Inc. Reports Earnings Results for the Nine Months Ended March 31, 2023	23-05-11	CI
Hangzhou Golong Holding Co., Ltd. agreed to acquire 10.7% stake in Soiken Holdings Inc. from Tomoko Kajimoto for ?1.1 billion.	21-11-16	CI
Soiken Holdings Inc.(TSE:2385) dropped from S&P Global BMI Index	21-09-20	CI
Soiken Holdings Inc.(TSE:2385) added to S&P Global BMI Index	18-09-24	CI
Soiken Holdings Inc. completed the acquisition of 64.5% stake in Nrl Pharma, Inc from Nobuko Ando, Hiroshi Koike, Jiro Yoshimura, Tatsuo Hoshino, Masao Hara and Kazuhiro Kaneko for approximately ¥570 million.	17-06-26	CI
Soiken Holdings Inc. signed a contract to acquire 58.6% stake in Nrl Pharma, Inc from Nobuko Ando, Hiroshi Koike, Jiro Yoshimura, Tatsuo Hoshino, Masao Hara and Kazuhiro Kaneko for approximately ¥500 million.	17-05-18	CI
Beautyplus Holdings Hongkong Limited cancelled the acquisition of 15% stake in BB Laboratories Incorporated from Soiken Holdings Inc..	16-05-26	CI
Soiken Holdings Inc. cancelled the acquisition of 15.1% stake in Trans-Asia Inc. from Tomonori Mori.	15-09-12	CI
Beautyplus Holdings Hongkong Limited agreed to acquire 15% stake in BB Laboratories Incorporated from Soiken Holdings Inc. for ¥120 million.	15-05-28	CI
Soiken Holdings Inc. agreed to acquire Trans-Asia Inc. for JPY 20 million.	14-09-12	CI

Soiken Holdings Inc. is a Japan-based holding company. The Company operates in six business segments. The Biological Evaluation System segment is engaged in evaluation test of food and research support of medicine. The Healthcare Support segment is engaged in the provision of service about certain health guidance and healthcare insurance. The Cosmetics segment is engaged in manufacturing and sales of cosmetics. The Dietary Supplements segment is engaged in sales of unique dietary supplements. The Marketing segment is engaged in the marketing research of health supplement and sales of energy drink. The Functional Material Development segment is engaged in development and sales of functional materials, such as lactoferrin.

Sector

Personal Products

Calendar

2024-05-12 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Soiken Holdings Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
SOIKEN HOLDINGS INC.	-0.60%	28.56M
L'ORÉAL	-2.31%	252B
KAO CORPORATION	+10.74%	19.38B
GALDERMA GROUP AG	0.00%	17.44B
SHISEIDO COMPANY, LIMITED	-1.46%	10.95B
COTY INC.	-5.80%	10.46B
AMOREPACIFIC CORPORATION	+0.28%	6.35B
PROYA COSMETICS CO.,LTD.	+11.64%	5.89B
NATURA &CO HOLDING S.A.	-2.66%	4.47B
INTER PARFUMS, INC.	-9.37%	4.2B

Cosmetics & Perfumes